Traws Pharma

TRAW · NASDAQ

$0.3767+$0.0102 (+2.78%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $0.3665

Latest news

NewsSep 28, 5:06 PM ET
12 Health Care Stocks Moving In Monday's After-Market Session
NewsSep 25, 4:40 AM ETAvi Kapoor
Why INLIF Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
Press releaseAug 14, 4:30 PM ETGlobe Newswire
Traws Pharma Reports Q2 2026 Financial Results and Provides Business Highlights
Press releaseJun 22, 7:00 AM ETGlobe Newswire
Traws Pharma Provides Updated Guidance on Influenza Prophylaxis Program
NewsJun 15, 11:10 AM ETVandana Singh
Traws Pharma Stock Falls As UK Regulator Delays Key Flu Study
Press releaseJun 12, 5:30 PM ETGlobe Newswire
Traws Pharma Provides Regulatory Update on Influenza Program
NewsMay 27, 8:48 AM ET
Traws Pharma Announces Advancement Of Its Novel Proprietary Broad-Spectrum Combination Anti-Viral Agent With Potential Utility Against Hantavirus, Ebola and Lassa
Press releaseMay 27, 8:45 AM ETGlobe Newswire
Traws Pharma Announces Antiviral Program Targeting Ongoing Hantavirus and Ebola Virus Disease Outbreaks
NewsMay 15, 7:11 AM ET
Earnings Scheduled For May 15, 2026
Press releaseMay 15, 7:00 AM ETGlobe Newswire
Traws Pharma Provides Business Highlights and Reports Q1 2026 Financial Results
NewsMay 11, 3:40 AM ETSnigdha Gairola
Chuck Schumer Blasts Trump, Elon Musk For Firing CDC And Port Health Workers As Hantavirus Scare Grips The World
NewsMay 8, 1:05 PM ET
12 Health Care Stocks Moving In Friday's Intraday Session
NewsMay 8, 10:41 AM ETVandana Singh
Traws Pharma Gains After Hantavirus Drug Development Update Amid Cruise Ship Outbreak
NewsMay 8, 8:05 AM ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
Press releaseMay 8, 7:30 AM ETGlobe Newswire
Traws Pharma to Advance Potential Clinical Candidates for the Treatment of Hantavirus Infections
NewsApr 29, 8:06 AM ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Press releaseApr 15, 4:01 PM ETGlobe Newswire
Traws Pharma Reports Full Year 2025 Results and Provides Business Highlights
NewsApr 15, 1:05 PM ET
12 Health Care Stocks Moving In Wednesday's Intraday Session
Press releaseApr 15, 8:15 AM ETGlobe Newswire
Traws Pharma Announces Up to $60 Million Private Placement Financing
NewsMar 13, 5:05 PM ET
12 Health Care Stocks Moving In Friday's After-Market Session
NewsMar 11, 5:06 PM ET
12 Health Care Stocks Moving In Wednesday's After-Market Session
NewsFeb 19, 12:05 PM ET
12 Health Care Stocks Moving In Thursday's Intraday Session
NewsDec 17, 9:26 AM ETVandana Singh
Traws Pharma's Oral COVID Drug Shows Comparable Results To Paxlovid
NewsNov 14, 12:06 PM ET
12 Health Care Stocks Moving In Friday's Intraday Session
Press releaseOct 30, 12:00 PM ETPRNewswire
ChemDiv Extends CMC Services Collaboration for Ratutrelvir, a Potential Best-in-Class COVID-19 Therapeutic Advancing in Phase 2 Clinical Trials
Press releaseOct 22, 6:40 PM ETPRNewswire
Dover, Delaware -- Expert Systems Inc., a leading life sciences accelerator, Supports Traws Pharma Phase 2 Clinical Studies of Ratutrelvir -- a Novel Ritonavir-Free Antiviral for COVID-19.
NewsSep 5, 8:07 AM ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
NewsAug 14, 8:08 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
NewsJun 3, 12:16 PM ETAvi Kapoor
Dow Gains Over 100 Points; US Job Openings Increase In April
NewsJun 3, 10:08 AM ETAvi Kapoor
US Stocks Mixed; Dollar General Posts Upbeat Earnings
Press releaseJan 23, 7:00 AM ETPRNewswire
Traws Pharma Announces Completion of Phase I Studies with Tivoxavir Marboxil, a Single Dose Oral Investigational Drug for the Treatment and Prevention of H5N1 Bird Flu
NewsJan 16, 4:05 PM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Press releaseJan 10, 5:55 PM ETPRNewswire
Expert Systems and Traws Pharma Report Breakthrough in H5N1Bird Flu Antiviral Program
NewsDec 30, 2:14 PM ETAvi Kapoor
Nasdaq Down Over 100 Points; US Pending Home Sales Increase In November
NewsDec 30, 12:55 PM ETAvi Kapoor
Crude Oil Gains 1%; Chicago PMI Falls In December
NewsDec 30, 10:07 AM ETAvi Kapoor
US Stocks Open Lower; Dow Tumbles 600 Points
Press releaseDec 30, 8:00 AM ETPRNewswire
Traws Pharma, Inc. Announces Financing up to $72.6 Million from Leading Healthcare Institutional Investors to Advance Tivoxavir Marboxil Development for H5N1 Bird Flu to Approval
NewsDec 23, 2:08 PM ETAvi Kapoor
Gold Moves Lower, Rumble Shares Jump
NewsDec 23, 12:58 PM ETAvi Kapoor
Nasdaq Surges Over 100 Points, US Durable Goods Orders Decline In November
NewsDec 23, 12:47 PM ETLekha Gupta
Traws Pharma Stock Rockets On Promising H5N1 Bird Flu Treatment Results
NewsDec 23, 10:00 AM ETAvi Kapoor
US Stocks Mixed, Dow Tumbles 150 Points
NewsDec 23, 7:38 AM ET
Market-Moving News for December 23rd
Press releaseDec 23, 7:00 AM ETPRNewswire
Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

12 Health Care Stocks Moving In Monday's After-Market Session

Why INLIF Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket

Traws Pharma Reports Q2 2026 Financial Results and Provides Business Highlights

Traws Pharma Provides Updated Guidance on Influenza Prophylaxis Program

Traws Pharma Stock Falls As UK Regulator Delays Key Flu Study

Traws Pharma Provides Regulatory Update on Influenza Program

Traws Pharma Announces Advancement Of Its Novel Proprietary Broad-Spectrum Combination Anti-Viral Agent With Potential Utility Against Hantavirus, Ebola and Lassa

Traws Pharma Announces Antiviral Program Targeting Ongoing Hantavirus and Ebola Virus Disease Outbreaks

Earnings Scheduled For May 15, 2026

Traws Pharma Provides Business Highlights and Reports Q1 2026 Financial Results

Chuck Schumer Blasts Trump, Elon Musk For Firing CDC And Port Health Workers As Hantavirus Scare Grips The World

12 Health Care Stocks Moving In Friday's Intraday Session

Traws Pharma Gains After Hantavirus Drug Development Update Amid Cruise Ship Outbreak

12 Health Care Stocks Moving In Friday's Pre-Market Session

Traws Pharma to Advance Potential Clinical Candidates for the Treatment of Hantavirus Infections

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Traws Pharma Reports Full Year 2025 Results and Provides Business Highlights

12 Health Care Stocks Moving In Wednesday's Intraday Session

Traws Pharma Announces Up to $60 Million Private Placement Financing

12 Health Care Stocks Moving In Friday's After-Market Session

12 Health Care Stocks Moving In Wednesday's After-Market Session

12 Health Care Stocks Moving In Thursday's Intraday Session

Traws Pharma's Oral COVID Drug Shows Comparable Results To Paxlovid

12 Health Care Stocks Moving In Friday's Intraday Session

ChemDiv Extends CMC Services Collaboration for Ratutrelvir, a Potential Best-in-Class COVID-19 Therapeutic Advancing in Phase 2 Clinical Trials

Dover, Delaware -- Expert Systems Inc., a leading life sciences accelerator, Supports Traws Pharma Phase 2 Clinical Studies of Ratutrelvir -- a Novel Ritonavir-Free Antiviral for COVID-19.

12 Health Care Stocks Moving In Friday's Pre-Market Session

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Dow Gains Over 100 Points; US Job Openings Increase In April

US Stocks Mixed; Dollar General Posts Upbeat Earnings

Traws Pharma Announces Completion of Phase I Studies with Tivoxavir Marboxil, a Single Dose Oral Investigational Drug for the Treatment and Prevention of H5N1 Bird Flu

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Expert Systems and Traws Pharma Report Breakthrough in H5N1Bird Flu Antiviral Program

Nasdaq Down Over 100 Points; US Pending Home Sales Increase In November

Crude Oil Gains 1%; Chicago PMI Falls In December

US Stocks Open Lower; Dow Tumbles 600 Points

Traws Pharma, Inc. Announces Financing up to $72.6 Million from Leading Healthcare Institutional Investors to Advance Tivoxavir Marboxil Development for H5N1 Bird Flu to Approval

Gold Moves Lower, Rumble Shares Jump

Nasdaq Surges Over 100 Points, US Durable Goods Orders Decline In November

Traws Pharma Stock Rockets On Promising H5N1 Bird Flu Treatment Results

US Stocks Mixed, Dow Tumbles 150 Points

Market-Moving News for December 23rd

Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu